


Incisive Genetics Revenue
Biotechnology Research • Vancouver, British Columbia, Canada • 11-20 Employees
Incisive Genetics revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Key Contacts at Incisive Genetics
Blair R. Leavitt
Co-Founder And Ceo
Pamela Wagner
Director - R&D Operations
Company overview
| Headquarters | 301 - 980 George Street, Vancouver, BC V6A 0H9, CA |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Neuroscience, Crispr, Gene Editing, Genome Editing, Huntington'S Disease |
| Employees | 11-20 |
| Socials |
Incisive Genetics Email Formats
Incisive Genetics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@incisivegenetics.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@incisivegenetics.com | 60% |
{first initial}.{last name} | j.doe@incisivegenetics.com | 26.7% |
{first initial} | j@incisivegenetics.com | 13.3% |
About Incisive Genetics
We are a Vancouver, Canada-based biotech firm focused on developing our innovative lipid nanoparticle (LNP) delivery platform for genetic therapies. We believe our proprietary platform provides a solution to the most critical challenge to effective CRISPR-based gene therapy — the effective and safe in vivo delivery of active gene editing machinery into target tissues. We have secured the exclusive worldwide license from the University of British Columbia to our foundational technology, and continue to build out our intellectual property and patent portfolio through additional research and development. Currently, we are focused on continued development of our innovative delivery platform for therapeutic gene editing cargoes. We have undertaken key research activities to support the development of our platform, achieving significant proof of concept data for effective in vivo gene editing. We have approached our studies in a systematic way that enables us to iterate on our foundational system. We are actively using our platform to develop strategies for multiple disease indications, as well as creating new product modifications. We are excited to be part of the Vancouver biotechnology community, in a city that is rapidly emerging as one of the most vibrant innovation hubs in North America.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Incisive Genetics has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
Incisive Genetics has never raised funding before.
Incisive Genetics Tech Stack
Discover the technologies and tools that power Incisive Genetics's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Miscellaneous
Miscellaneous
Page builders
JavaScript libraries
JavaScript libraries
Frequently asked questions
4.8
40,000 users



